Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Roundup Xtend Approval Leads to Calls For Release of Public Records on EPA Communication with Monsanto September 11, 2017 Irvin Jackson Add Your Comments An environmental group is seeking information about communications between federal regulators and Monsanto, after a new formulation of the company’s Roundup weed killer was approved amid concerns about the risks associated with exposure to the glyphosate-based herbicide, indicating that there was no public input or discussion about the sudden regulatory decision. The Center for Biological Diversity issued a press release on September 7, announcing that it has submitted a Freedom of Information Act request for documents involving the U.S. Environmental Protection Agency (EPA) communications with Monsanto over the fast-track approval of Roundup Xtend, which combines the controversial herbicides glyphosate and dicamba. Glyphosate has been the active ingredient in Roundup for decades, but in 2015 the World Health Organization’s International Agency for Research on Cancer (IARC) determined that glyphosate was a probable carcinogen, linking Roundup to an increased risk of non-Hodgkins lymphoma. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Dicamba is a synthetic herbicide, which has been used for years by farmer’s nationwide to control weeds. However it was previously used only during certain times of years. A recent dicamba class action lawsuit claims that Monsanto and BASF released a new dicamba-tolerant crop system last year, which resulted in widespread use and caused dicamba to drift over non-tolerant fields, causing millions in crop damage and yield loss. According to the Center for Biological Diversity, Roundup Xtend will escalate the damage from dicamba, as well as continue widespread glyphosate exposure. It was developed to be sprayed on crops that are genetically engineered to be both “Roundup Ready” and dicamba resistant. The group indicates that the new version of the controversial weedkiller was quietly approved under the obscure name “M1769 premix herbicide,” with no public notice or public comment. Last year, the EPA reportedly amended the name at Monsanto’s request to “Roundup XTend with VaporGrip Technology.” “This herbicide is projected to become the most-used pesticide in agriculture, yet the EPA approved it with zero public input,” Nathan Donley, a senior scientist with the Center, said in the press release. “It raises serious questions about the far-too-cozy relationship between the EPA and Monsanto. Any product that increases the use of a dangerous pesticide like dicamba is bad news for wildlife and human health.” There has been growing concern over the relationship between Monsanto and the EPA in recent months, as internal memos and discovery have been released as part of Roundup lawsuits being pursued against the manufacturer by individual diagnosed with non-Hodgkins lymphoma. On August 1, a cache of internal memos and e-mails, being referred to as the “Monsanto Papers”, were released to the public as part of the on-going litigation involving cases filed by hundreds of farmers, landscapers, agricultural workers and other regular users of the weedkiller, which alleges that the manufacturer failed to adequately warn about the potential cancer risks and importance of taking safety precautions while spraying the weedkiller. In addition to documents showing Monsanto working with the EPA, and its own scientists raising concerns about whether glyphosate can cause cancer, the documents also indicated that Monsanto has edited and ghostwritten both supposedly independent research papers which heralded glyphosate’s safety, and meddled with the content of federal safety reviews. “Recent revelations paint a disturbing picture of potential collusion between Monsanto and EPA’s Office of Pesticide Programs,” the Center’s press release states. “The EPA’s Office of Inspector General has opened an investigation into the matter following revelations that multiple high-ranking officials in the pesticide office were in direct communication with the agrochemical giant while trying to quash an investigation by the Department of Health and Human Services into the safety of glyphosate.” Roundup Litigation According to allegations raised in non-Hodgkins lymphoma lawsuits filed against Monsanto, plaintiffs claim that their cancer diagnosis may have been avoided if adequate warnings had been provided, and if Monsanto had not taken steps to falsify data and mislead about the safety of the weedkiller. Given the similar questions of fact and law presented in lawsuits filed throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for all federal Roundup cases in October 2016, centralizing the claims before U.S. District Judge Vince Chhabria in the Northern District of California to reduce duplicative discovery, prevent conflicting rulings and serve the convenience of the parties, witnesses and the courts. As part of the coordinated MDL proceedings, Judge Chhabria has previously determined that the Roundup litigation will be bifurcated, first addressing general causation about the link between the widely used weedkiller and non-Hodgkins lymphoma, before addressing case-specific issues about whether Roundup caused cancer for each individual plaintiff. Following resolution of any motions to dismiss based on general causation, if a Roundup settlement or other resolution for the litigation is not reached during the first phase of discovery, it is expected that Judge Chhabria will establish a bellwether process, where a small group of cases will be prepared for early trial dates to help gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the lawsuits. Tags: Cancer, Dicamba, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits July 1, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: today) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025) Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: today) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: today) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 4 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)